Design, Construction, and Application of Transcription Activation-Like Effectors

  • Peter Deng
  • Sakereh Carter
  • Kyle FinkEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1937)


Transcription activator-like effectors (TALEs) are modular proteins derived from the plant Xanthomonas sp. pathogen that can be designed to target unique DNA sequences following a simple cipher. Customized TALE proteins can be used in a variety of molecular applications that include gene editing and transcriptional modulation. Presently, we provide a brief primer on the design and construction of TALEs. TALE proteins can be fused to a variety of different effector domains that alter the function of the TALE upon binding. This flexibility of TALE design and downstream effect may offer therapeutic applications that are discussed in this section. Finally, we provide a future perspective on TALE technology and what challenges remain for successful translation of gene-editing strategies to the clinic.

Key words

Gene editing TALEs Nucleases Artificial transcription factor Chromatin remodeling DNA binding Huntington’s disease 


  1. 1.
    Boch J, Scholze H, Schornack S et al (2009) Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science 326(80):1509–1512. Scholar
  2. 2.
    Mak AN-S, Bradley P, Cernadas RA et al (2012) The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335:716–719. Scholar
  3. 3.
    Streubel J, Blücher C, Landgraf A, Boch J (2012) TAL effector RVD specificities and efficiencies. Nat Biotechnol 30:593–595. Scholar
  4. 4.
    Deng D, Yin P, Yan C et al (2012) Recognition of methylated DNA by TAL effectors. Cell Res 22:1502–1504. Scholar
  5. 5.
    Guilinger JP, Pattanayak V, Reyon D et al (2014) Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods 11:429–435. Scholar
  6. 6.
    Römer P, Recht S, Strauß T et al (2010) Promoter elements of rice susceptibility genes are bound and activated by specific TAL effectors from the bacterial blight pathogen, Xanthomonas oryzae pv. oryzae. New Phytol 187:1048–1057. Scholar
  7. 7.
    Lamb BM, Mercer AC, Barbas CF (2013) Directed evolution of the TALE N-terminal domain for recognition of all 5′ bases. Nucleic Acids Res 41:9779–9785. Scholar
  8. 8.
    Meckler JF, Bhakta MS, Kim M-S et al (2013) Quantitative analysis of TALE-DNA interactions suggests polarity effects. Nucleic Acids Res 41:4118–4128. Scholar
  9. 9.
    Cermak T, Doyle EL, Christian M et al (2011) Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39:e82. Scholar
  10. 10.
    Zhang F, Cong L, Lodato S et al (2011) Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29:149–153. Scholar
  11. 11.
    Gaj T, Gersbach CA, Barbas CF III (2013) ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol 31:397–405. Scholar
  12. 12.
    Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49–55. Scholar
  13. 13.
    Cong L, Zhou R, Kuo Y et al (2012) Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun 3:968. Scholar
  14. 14.
    Miller JC, Tan S, Qiao G et al (2011) A TALE nuclease architecture for efficient genome editing. Nat Biotechnol 29:143–148. Scholar
  15. 15.
    Li T, Huang S, Jiang WZ et al (2011) TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res 39:359–372. Scholar
  16. 16.
    Wood AJ, Lo T-W, Zeitler B et al (2011) Targeted genome editing across species using ZFNs and TALENs. Science 333(80):307–307. Scholar
  17. 17.
    Tesson L, Usal C, Ménoret S et al (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29:695–696. Scholar
  18. 18.
    Wefers B, Meyer M, Ortiz O et al (2013) Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. Proc Natl Acad Sci U S A 110:3782–3787. Scholar
  19. 19.
    Sato K, Oiwa R, Kumita W et al (2016) Generation of a nonhuman primate model of severe combined immunodeficiency using highly efficient genome editing. Cell Stem Cell 19:127–138. Scholar
  20. 20.
    Carlson DF, Tan W, Lillico SG et al (2012) Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci 109:17382–17387. Scholar
  21. 21.
    Kim E, Kim S, Kim DH et al (2012) Precision genome engineering with programmable DNA-nicking enzymes. Genome Res 22:1327–1333. Scholar
  22. 22.
    Wu H, Wang Y, Zhang Y et al (2015) TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proc Natl Acad Sci U S A 112:E1530–E1539. Scholar
  23. 23.
    Wang X, Wang Y, Wu X et al (2015) Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33:175–178. Scholar
  24. 24.
    Ran FA, Hsu PD, Lin C-Y et al (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380–1389. Scholar
  25. 25.
    Qasim W, Thrasher AJ (2014) Progress and prospects for engineered T cell therapies. Br J Haematol 166:818–829. Scholar
  26. 26.
    Maeder ML, Linder SJ, Reyon D et al (2013) Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 10:243–245. Scholar
  27. 27.
    Bultmann S, Morbitzer R, Schmidt CS et al (2012) Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 40:5368–5377. Scholar
  28. 28.
    Gao X, Tsang JCH, Gaba F et al (2014) Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Res 42:e155. Scholar
  29. 29.
    Perez-Pinera P, Ousterout DG, Brunger JM et al (2013) Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods 10:239–242. Scholar
  30. 30.
    Uhde-Stone C, Cheung E, Lu B (2014) TALE activators regulate gene expression in a position- and strand-dependent manner in mammalian cells. Biochem Biophys Res Commun 443:1189–1194. Scholar
  31. 31.
    Zhang Z, Xiang D, Heriyanto F et al (2013) Dissecting the roles of miR-302/367 cluster in cellular reprogramming using TALE-based repressor and TALEN. Stem Cell Reports 1:218–225. Scholar
  32. 32.
    Amabile A, Migliara A, Capasso P et al (2016) Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167:219–232.e14. Scholar
  33. 33.
    Fink KD, Deng P, Gutierrez J et al (2016) Allele-Specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human huntington’s disease fibroblasts. Cell Transplant 25:677–686. Scholar
  34. 34.
    Holkers M, Maggio I, Liu J et al (2013) Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41:e63–e63. Scholar
  35. 35.
    Yang L, Guell M, Byrne S et al (2013) Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41:9049–9061. Scholar
  36. 36.
    Hathaway NA, Bell O, Hodges C et al (2012) Dynamics and memory of heterochromatin in living cells. Cell 149:1447–1460. Scholar
  37. 37.
    Munye MM, Tagalakis AD, Barnes JL et al (2016) Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer. Sci Rep 6:23125. Scholar
  38. 38.
    Lewis O, Woolley M, Johnson D et al (2016) Chronic, intermittent convection-enhanced delivery devices. J Neurosci Methods 259:47–56. Scholar
  39. 39.
    Kay MA, He C-Y, Chen Z-Y (2010) A robust system for production of minicircle DNA vectors. Nat Biotechnol 28:1287–1289. Scholar
  40. 40.
    Lu J, Zhang F, Kay MA (2013) A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. Mol Ther 21:954–963. Scholar
  41. 41.
    Lu J, Williams JA, Luke J et al (2017) A 5′ noncoding exon containing engineered intron enhances transgene expression from recombinant AAV vectors in vivo. Hum Gene Ther 28:125–134. Scholar
  42. 42.
    Montague TG, Cruz JM, Gagnon JA et al (2014) CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res 42:W401–W407. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Stem Cell Program and Institute for Regenerative CuresUniversity of California, DavisSacramentoUSA
  2. 2.Genome Center, MIND Institute, and Biochemistry and Molecular MedicineUniversity of California, DavisDavisUSA
  3. 3.Department of NeurologyUniversity of California Davis SacramentoUSA

Personalised recommendations